NO163452C - Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemderivater. - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemderivater.

Info

Publication number
NO163452C
NO163452C NO861630A NO861630A NO163452C NO 163452 C NO163452 C NO 163452C NO 861630 A NO861630 A NO 861630A NO 861630 A NO861630 A NO 861630A NO 163452 C NO163452 C NO 163452C
Authority
NO
Norway
Prior art keywords
sup
group
sub
hydrogen atom
atom
Prior art date
Application number
NO861630A
Other languages
English (en)
Norwegian (no)
Other versions
NO861630L (no
NO163452B (no
Inventor
Isao Kawamoto
Rokuro Endo
Masayuki Iwata
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO861630L publication Critical patent/NO861630L/no
Publication of NO163452B publication Critical patent/NO163452B/no
Publication of NO163452C publication Critical patent/NO163452C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
NO861630A 1985-04-27 1986-04-25 Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemderivater. NO163452C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9198885 1985-04-27

Publications (3)

Publication Number Publication Date
NO861630L NO861630L (no) 1986-10-28
NO163452B NO163452B (no) 1990-02-19
NO163452C true NO163452C (no) 1990-05-30

Family

ID=14041841

Family Applications (1)

Application Number Title Priority Date Filing Date
NO861630A NO163452C (no) 1985-04-27 1986-04-25 Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemderivater.

Country Status (17)

Country Link
US (1) US4771046A (de)
EP (1) EP0202048B1 (de)
JP (1) JPH0710868B2 (de)
KR (1) KR920010076B1 (de)
AT (1) ATE69053T1 (de)
AU (1) AU583113B2 (de)
CA (1) CA1305709C (de)
DE (1) DE3682225D1 (de)
DK (1) DK189686A (de)
ES (1) ES8800952A1 (de)
FI (1) FI81577C (de)
HU (1) HU194882B (de)
IE (1) IE58892B1 (de)
NO (1) NO163452C (de)
NZ (1) NZ215957A (de)
PH (1) PH22555A (de)
ZA (1) ZA863109B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0759581B2 (ja) * 1986-09-05 1995-06-28 日本レダリ−株式会社 (1r)−1−メチルカルバペネム−3−カルボン酸誘導体
JPS6425780A (en) * 1987-04-28 1989-01-27 Sankyo Co 1-methylcarbapenem derivative
IE910606A1 (en) * 1990-02-23 1991-08-28 Sankyo Co Carbapenem derivatives having antibiotic activity, their¹preparation and their use
US5712267A (en) * 1991-06-04 1998-01-27 Sankyo Company,. Limited Carbapenem derivatives, their preparation and their use as antibiotics
KR970706284A (ko) 1994-09-16 1997-11-03 나가사까 겐지로 신규의 카르바페넴 유도체(novel carbapenem deriative)
CA2199855A1 (en) * 1994-09-16 1996-03-21 Ryosuke Ushijima Novel carbapenem derivative
US5932048A (en) * 1995-04-06 1999-08-03 Komatsu Electronic Metals Co., Ltd. Method of fabricating direct-bonded semiconductor wafers
US20070234661A1 (en) * 2005-01-28 2007-10-11 Ed Vaes Multi piece curved moldings

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0017992A1 (de) * 1979-04-19 1980-10-29 Merck & Co. Inc. 2-Substituierte-6-substituierte-1-Carbadethiapen-2-em-3-carbonsäuren, Verfahren zu ihrer Herstellung, sie enthaltende antibiotische pharmazeutische Zusammensetzungen und Verfahren zur Herstellung von Zwischenprodukten
PT73791B (en) * 1980-10-17 1983-10-14 Merck & Co Inc Process for preparing 2-carbamimidoyl-6-substituted-1- -carbadethiapen-2-em-3-carboxylic acids
EP0060612A1 (de) * 1981-02-04 1982-09-22 Beecham Group Plc Verfahren zur Herstellung von Azabicyclo(3.2.0)-hept-2-en-Derivaten
ES514240A0 (es) * 1981-08-03 1984-04-16 Merck & Co Inc Un procedimiento para la prepracion de nuevos derivados de acidos 2-carbamimidoil-1-,carbadestiapen-2-en-3-carboxilados.
JPS60178888A (ja) * 1984-02-22 1985-09-12 Sankyo Co Ltd ペネムまたはカルバペネム誘導体およびその製法

Also Published As

Publication number Publication date
CA1305709C (en) 1992-07-28
DK189686A (da) 1986-10-28
JPS6230781A (ja) 1987-02-09
NZ215957A (en) 1988-04-29
AU583113B2 (en) 1989-04-20
HU194882B (en) 1988-03-28
EP0202048B1 (de) 1991-10-30
NO861630L (no) 1986-10-28
EP0202048A1 (de) 1986-11-20
US4771046A (en) 1988-09-13
KR920010076B1 (ko) 1992-11-13
DK189686D0 (da) 1986-04-24
PH22555A (en) 1988-10-17
AU5671086A (en) 1986-10-30
ES554474A0 (es) 1987-12-01
FI861763A (fi) 1986-10-28
JPH0710868B2 (ja) 1995-02-08
FI81577C (fi) 1990-11-12
IE58892B1 (en) 1993-12-01
FI81577B (fi) 1990-07-31
DE3682225D1 (de) 1991-12-05
KR860008178A (ko) 1986-11-12
ES8800952A1 (es) 1987-12-01
NO163452B (no) 1990-02-19
HUT40661A (en) 1987-01-28
ZA863109B (en) 1986-12-30
FI861763A0 (fi) 1986-04-25
IE861106L (en) 1986-10-27
ATE69053T1 (de) 1991-11-15

Similar Documents

Publication Publication Date Title
SE7906000L (sv) Terapeutiskt aktiva, substituerade piperidiner och pyrrolidiner
ES513109A0 (es) "procedimiento de preparacion de derivados de 1-fenil-1-hidroxi-etilamina".
DE68917023D1 (de) 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-en-2-carbonsäureverbindungen.
NO173867C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamider
AU531586B2 (en) Morpholine derivatives
NO166126C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
NO163452C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemderivater.
HU9202294D0 (en) Method for producing new medical preparatives containing diphenyl-imidazole derivatives and their active agents
IE790630L (en) 2, 6-dialkoxybenzamido-pyrrolidines.
ES473441A1 (es) Procedimiento para la preparacion de nuevos derivados de 5,-11-dihidro-6h-pirido (2,3-b)(1,4-benzodiazepin-6-ona).
IE791881L (en) Chromanol derivatives
EP0123962A3 (en) Novel benzimidazole derivative, process for the preparation thereof and pharmaceutical composition
TW280810B (de)
GB1433103A (en) Pharmacologically active pyrrolodiazepines
DK424888D0 (da) Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater
DK0471856T3 (da) 15-Deoxyprostaglandin-derivater
ATE6514T1 (de) Clavulansaeure-derivate, ihre herstellung und pharmazeutische zubereitungen.
EP0272849A3 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases